Tairawhiti-based medicinal hashish firm Rua Bioscience has struck an export partnership deal with a German distributor.

The firm instructed the New Zealand Herald it had secured a deal with Nimbus Health, an unbiased pharmaceutical wholesaler which specialises in importing and distributing pharmaceutical-grade medicinal hashish merchandise in Germany.

Rua Bioscience CEO Rob Mitchell mentioned Germany was Europe’s most mature medicinal hashish market and he was proud to be the primary firm to announce a binding export settlement from there.

“We are aiming to fulfil the first exports under the partnership in the second half of 2021,” he mentioned.

“While at this time we are not in a position to confirm specific quantities or the value of the agreement, it is likely to amount to a few hundred kilograms in the first year of operation to a few thousand kilograms within three years.”

The settlement means Rua Bioscience is Nimbus Health’s unique New Zealand provider.

“We are creating unique cannabis medicines together to serve the patient base in Germany more efficiently,” he mentioned.

“This provides certainty for our production goals and signals international confidence in our ability to produce pharmaceutical-grade cannabis medicines.” [Read more @ The Gisborne Herald]

Source link